NOVEL GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO

The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO69122, PRO204, PRO214, PRO222, PRO234, PRO265, PRO309, PRO332, PRO342,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PAYNE, BOBBY, JOE, RANGEL, CAROLINA, QIAN, NI, NANCY, MASSEY, ERIN, MARIE, YE, WEILAN, COMBS, KATHERIN, STALA, JOY, WILLIS-SEVAUX, TRACY, ELLEN, JUNGE, HARALD, SHI, ZHENG-ZHENG, VOGEL, PETER, MONTGOMERY, CHUCK, MCLAIN, DINA, REBECCA, PHILLIPS, HEIDI, SPARKS, MARY, JEAN, DING, ZHIYONG, JUNUTULA, JAGATH, REDDY, EDWARDS, JOEL, DESAUVAGE, FREDERIC, GIRGIS, ROSEMARY, BYERS-HORNER, ALLISON, ANNE, CULBERTSON, LING, LING
Format: Patent
Sprache:eng ; fre
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PAYNE, BOBBY, JOE
RANGEL, CAROLINA
QIAN, NI, NANCY
MASSEY, ERIN, MARIE
YE, WEILAN
COMBS, KATHERIN
STALA, JOY
WILLIS-SEVAUX, TRACY, ELLEN
JUNGE, HARALD
SHI, ZHENG-ZHENG
VOGEL, PETER
MONTGOMERY, CHUCK
MCLAIN, DINA, REBECCA
PHILLIPS, HEIDI
SPARKS, MARY, JEAN
DING, ZHIYONG
JUNUTULA, JAGATH, REDDY
EDWARDS, JOEL
DESAUVAGE, FREDERIC
GIRGIS, ROSEMARY
BYERS-HORNER, ALLISON, ANNE
CULBERTSON, LING, LING
description The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO69122, PRO204, PRO214, PRO222, PRO234, PRO265, PRO309, PRO332, PRO342, PRO356, PRO540, PRO618, PRO944, PRO994, PRO1079, PRO1110, PRO1122, PRO1138, PRO1190, PRO1272, PRO1286, PRO1295, PRO1309, PRO1316, PRO1383, PRO1384, PRO1431, PRO1434, PRO1475, PRO1481, PRO1568, PRO1573, PRO1599, PRO1604, PRO1605, PRO1693, PRO1753, PRO1755, PRO1777, PRO1788, PRO1864, PRO1925, PRO1926, PRO3566, PRO4330, PRO4423, PRO36935, PRO4977, PRO4979, PRO4980, PRO4981, PRO5801, PRO5995, PRO6001, PRO6095, PRO6182, PRO7170, PRO7171, PRO7436, PRO9912, PRO9917, PRO37337, PRO37496, PRO19646, PRO21718, PRO19820, PRO21201, PRO20026, PRO20110, PRO23203 or PRO35250 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities. La présente invention concerne des animaux transgéniques ainsi que des compositions et des procédés se rapportant à la caractérisation de la fonction génique. De manière plus spécifique, cette invention porte sur des souris transgéniques comprenant des disruptions dans les gènes PRO69122, PRO204, PRO214, PRO222, PRO234, PRO265, PRO309, PRO332, PRO342, PRO356, PRO540, PRO618, PRO944, PRO994, PRO1079, PRO1110, PRO1122, PRO1138, PRO1190, PRO1272, PRO1286, PRO1295, PRO1309, PRO1316, PRO1383, PRO1384, PRO1431, PRO1434, PRO1475, PRO1481, PRO1568, PRO1573, PRO1599, PRO1604, PRO1605, PRO1693, PRO1753, PRO1755, PRO1777, PRO1788, PRO1864, PRO1925, PRO1926, PRO3566, PRO4330, PRO4423, PRO36935, PRO4977, PRO4979, PRO4980, PRO4981, PRO5801, PRO5995, PRO6001, PRO6095, PRO6182, PRO7170, PRO7171, PRO7436, PRO9912, PRO9917, PRO37337, PRO37496, PRO19646, PRO21718, PRO19820, PRO21201, PRO20026, PRO20110, PRO23203 ou PRO35250. De telles études et caractérisations in vivo peuvent assurer une identification intéressante et la découverte de thérapies et/ou de traitements utiles dans la prévention, l'amélioration ou la correction de maladi
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2006132788A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2006132788A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2006132788A23</originalsourceid><addsrcrecordid>eNrjZHD08w9z9VFwd_VzVXDxDA4KDQjx9PcL1lFw9vcN8A_2BPMUHP1cFHxdQzz8XYIVglx9HEM8_dwVQjxcg1xD_HkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBgZmhsZG5hYWjkTFxqgCpWyw2</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO</title><source>esp@cenet</source><creator>PAYNE, BOBBY, JOE ; RANGEL, CAROLINA ; QIAN, NI, NANCY ; MASSEY, ERIN, MARIE ; YE, WEILAN ; COMBS, KATHERIN ; STALA, JOY ; WILLIS-SEVAUX, TRACY, ELLEN ; JUNGE, HARALD ; SHI, ZHENG-ZHENG ; VOGEL, PETER ; MONTGOMERY, CHUCK ; MCLAIN, DINA, REBECCA ; PHILLIPS, HEIDI ; SPARKS, MARY, JEAN ; DING, ZHIYONG ; JUNUTULA, JAGATH, REDDY ; EDWARDS, JOEL ; DESAUVAGE, FREDERIC ; GIRGIS, ROSEMARY ; BYERS-HORNER, ALLISON, ANNE ; CULBERTSON, LING, LING</creator><creatorcontrib>PAYNE, BOBBY, JOE ; RANGEL, CAROLINA ; QIAN, NI, NANCY ; MASSEY, ERIN, MARIE ; YE, WEILAN ; COMBS, KATHERIN ; STALA, JOY ; WILLIS-SEVAUX, TRACY, ELLEN ; JUNGE, HARALD ; SHI, ZHENG-ZHENG ; VOGEL, PETER ; MONTGOMERY, CHUCK ; MCLAIN, DINA, REBECCA ; PHILLIPS, HEIDI ; SPARKS, MARY, JEAN ; DING, ZHIYONG ; JUNUTULA, JAGATH, REDDY ; EDWARDS, JOEL ; DESAUVAGE, FREDERIC ; GIRGIS, ROSEMARY ; BYERS-HORNER, ALLISON, ANNE ; CULBERTSON, LING, LING</creatorcontrib><description>The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO69122, PRO204, PRO214, PRO222, PRO234, PRO265, PRO309, PRO332, PRO342, PRO356, PRO540, PRO618, PRO944, PRO994, PRO1079, PRO1110, PRO1122, PRO1138, PRO1190, PRO1272, PRO1286, PRO1295, PRO1309, PRO1316, PRO1383, PRO1384, PRO1431, PRO1434, PRO1475, PRO1481, PRO1568, PRO1573, PRO1599, PRO1604, PRO1605, PRO1693, PRO1753, PRO1755, PRO1777, PRO1788, PRO1864, PRO1925, PRO1926, PRO3566, PRO4330, PRO4423, PRO36935, PRO4977, PRO4979, PRO4980, PRO4981, PRO5801, PRO5995, PRO6001, PRO6095, PRO6182, PRO7170, PRO7171, PRO7436, PRO9912, PRO9917, PRO37337, PRO37496, PRO19646, PRO21718, PRO19820, PRO21201, PRO20026, PRO20110, PRO23203 or PRO35250 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities. La présente invention concerne des animaux transgéniques ainsi que des compositions et des procédés se rapportant à la caractérisation de la fonction génique. De manière plus spécifique, cette invention porte sur des souris transgéniques comprenant des disruptions dans les gènes PRO69122, PRO204, PRO214, PRO222, PRO234, PRO265, PRO309, PRO332, PRO342, PRO356, PRO540, PRO618, PRO944, PRO994, PRO1079, PRO1110, PRO1122, PRO1138, PRO1190, PRO1272, PRO1286, PRO1295, PRO1309, PRO1316, PRO1383, PRO1384, PRO1431, PRO1434, PRO1475, PRO1481, PRO1568, PRO1573, PRO1599, PRO1604, PRO1605, PRO1693, PRO1753, PRO1755, PRO1777, PRO1788, PRO1864, PRO1925, PRO1926, PRO3566, PRO4330, PRO4423, PRO36935, PRO4977, PRO4979, PRO4980, PRO4981, PRO5801, PRO5995, PRO6001, PRO6095, PRO6182, PRO7170, PRO7171, PRO7436, PRO9912, PRO9917, PRO37337, PRO37496, PRO19646, PRO21718, PRO19820, PRO21201, PRO20026, PRO20110, PRO23203 ou PRO35250. De telles études et caractérisations in vivo peuvent assurer une identification intéressante et la découverte de thérapies et/ou de traitements utiles dans la prévention, l'amélioration ou la correction de maladies et de dysfonctionnements associés aux disruptions géniques telles que les troubles neurologiques; les troubles cardio-vasculaires, endothéliaux ou angiogéniques; les anomalies de l'oeil; les troubles immunologiques; les troubles oncologiques; les anomalies ou les troubles du métabolisme osseux; les troubles du métabolisme des lipides; ou les troubles de la croissance.</description><language>eng ; fre</language><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20061214&amp;DB=EPODOC&amp;CC=WO&amp;NR=2006132788A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20061214&amp;DB=EPODOC&amp;CC=WO&amp;NR=2006132788A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PAYNE, BOBBY, JOE</creatorcontrib><creatorcontrib>RANGEL, CAROLINA</creatorcontrib><creatorcontrib>QIAN, NI, NANCY</creatorcontrib><creatorcontrib>MASSEY, ERIN, MARIE</creatorcontrib><creatorcontrib>YE, WEILAN</creatorcontrib><creatorcontrib>COMBS, KATHERIN</creatorcontrib><creatorcontrib>STALA, JOY</creatorcontrib><creatorcontrib>WILLIS-SEVAUX, TRACY, ELLEN</creatorcontrib><creatorcontrib>JUNGE, HARALD</creatorcontrib><creatorcontrib>SHI, ZHENG-ZHENG</creatorcontrib><creatorcontrib>VOGEL, PETER</creatorcontrib><creatorcontrib>MONTGOMERY, CHUCK</creatorcontrib><creatorcontrib>MCLAIN, DINA, REBECCA</creatorcontrib><creatorcontrib>PHILLIPS, HEIDI</creatorcontrib><creatorcontrib>SPARKS, MARY, JEAN</creatorcontrib><creatorcontrib>DING, ZHIYONG</creatorcontrib><creatorcontrib>JUNUTULA, JAGATH, REDDY</creatorcontrib><creatorcontrib>EDWARDS, JOEL</creatorcontrib><creatorcontrib>DESAUVAGE, FREDERIC</creatorcontrib><creatorcontrib>GIRGIS, ROSEMARY</creatorcontrib><creatorcontrib>BYERS-HORNER, ALLISON, ANNE</creatorcontrib><creatorcontrib>CULBERTSON, LING, LING</creatorcontrib><title>NOVEL GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO</title><description>The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO69122, PRO204, PRO214, PRO222, PRO234, PRO265, PRO309, PRO332, PRO342, PRO356, PRO540, PRO618, PRO944, PRO994, PRO1079, PRO1110, PRO1122, PRO1138, PRO1190, PRO1272, PRO1286, PRO1295, PRO1309, PRO1316, PRO1383, PRO1384, PRO1431, PRO1434, PRO1475, PRO1481, PRO1568, PRO1573, PRO1599, PRO1604, PRO1605, PRO1693, PRO1753, PRO1755, PRO1777, PRO1788, PRO1864, PRO1925, PRO1926, PRO3566, PRO4330, PRO4423, PRO36935, PRO4977, PRO4979, PRO4980, PRO4981, PRO5801, PRO5995, PRO6001, PRO6095, PRO6182, PRO7170, PRO7171, PRO7436, PRO9912, PRO9917, PRO37337, PRO37496, PRO19646, PRO21718, PRO19820, PRO21201, PRO20026, PRO20110, PRO23203 or PRO35250 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities. La présente invention concerne des animaux transgéniques ainsi que des compositions et des procédés se rapportant à la caractérisation de la fonction génique. De manière plus spécifique, cette invention porte sur des souris transgéniques comprenant des disruptions dans les gènes PRO69122, PRO204, PRO214, PRO222, PRO234, PRO265, PRO309, PRO332, PRO342, PRO356, PRO540, PRO618, PRO944, PRO994, PRO1079, PRO1110, PRO1122, PRO1138, PRO1190, PRO1272, PRO1286, PRO1295, PRO1309, PRO1316, PRO1383, PRO1384, PRO1431, PRO1434, PRO1475, PRO1481, PRO1568, PRO1573, PRO1599, PRO1604, PRO1605, PRO1693, PRO1753, PRO1755, PRO1777, PRO1788, PRO1864, PRO1925, PRO1926, PRO3566, PRO4330, PRO4423, PRO36935, PRO4977, PRO4979, PRO4980, PRO4981, PRO5801, PRO5995, PRO6001, PRO6095, PRO6182, PRO7170, PRO7171, PRO7436, PRO9912, PRO9917, PRO37337, PRO37496, PRO19646, PRO21718, PRO19820, PRO21201, PRO20026, PRO20110, PRO23203 ou PRO35250. De telles études et caractérisations in vivo peuvent assurer une identification intéressante et la découverte de thérapies et/ou de traitements utiles dans la prévention, l'amélioration ou la correction de maladies et de dysfonctionnements associés aux disruptions géniques telles que les troubles neurologiques; les troubles cardio-vasculaires, endothéliaux ou angiogéniques; les anomalies de l'oeil; les troubles immunologiques; les troubles oncologiques; les anomalies ou les troubles du métabolisme osseux; les troubles du métabolisme des lipides; ou les troubles de la croissance.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHD08w9z9VFwd_VzVXDxDA4KDQjx9PcL1lFw9vcN8A_2BPMUHP1cFHxdQzz8XYIVglx9HEM8_dwVQjxcg1xD_HkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBgZmhsZG5hYWjkTFxqgCpWyw2</recordid><startdate>20061214</startdate><enddate>20061214</enddate><creator>PAYNE, BOBBY, JOE</creator><creator>RANGEL, CAROLINA</creator><creator>QIAN, NI, NANCY</creator><creator>MASSEY, ERIN, MARIE</creator><creator>YE, WEILAN</creator><creator>COMBS, KATHERIN</creator><creator>STALA, JOY</creator><creator>WILLIS-SEVAUX, TRACY, ELLEN</creator><creator>JUNGE, HARALD</creator><creator>SHI, ZHENG-ZHENG</creator><creator>VOGEL, PETER</creator><creator>MONTGOMERY, CHUCK</creator><creator>MCLAIN, DINA, REBECCA</creator><creator>PHILLIPS, HEIDI</creator><creator>SPARKS, MARY, JEAN</creator><creator>DING, ZHIYONG</creator><creator>JUNUTULA, JAGATH, REDDY</creator><creator>EDWARDS, JOEL</creator><creator>DESAUVAGE, FREDERIC</creator><creator>GIRGIS, ROSEMARY</creator><creator>BYERS-HORNER, ALLISON, ANNE</creator><creator>CULBERTSON, LING, LING</creator><scope>EVB</scope></search><sort><creationdate>20061214</creationdate><title>NOVEL GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO</title><author>PAYNE, BOBBY, JOE ; RANGEL, CAROLINA ; QIAN, NI, NANCY ; MASSEY, ERIN, MARIE ; YE, WEILAN ; COMBS, KATHERIN ; STALA, JOY ; WILLIS-SEVAUX, TRACY, ELLEN ; JUNGE, HARALD ; SHI, ZHENG-ZHENG ; VOGEL, PETER ; MONTGOMERY, CHUCK ; MCLAIN, DINA, REBECCA ; PHILLIPS, HEIDI ; SPARKS, MARY, JEAN ; DING, ZHIYONG ; JUNUTULA, JAGATH, REDDY ; EDWARDS, JOEL ; DESAUVAGE, FREDERIC ; GIRGIS, ROSEMARY ; BYERS-HORNER, ALLISON, ANNE ; CULBERTSON, LING, LING</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2006132788A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2006</creationdate><toplevel>online_resources</toplevel><creatorcontrib>PAYNE, BOBBY, JOE</creatorcontrib><creatorcontrib>RANGEL, CAROLINA</creatorcontrib><creatorcontrib>QIAN, NI, NANCY</creatorcontrib><creatorcontrib>MASSEY, ERIN, MARIE</creatorcontrib><creatorcontrib>YE, WEILAN</creatorcontrib><creatorcontrib>COMBS, KATHERIN</creatorcontrib><creatorcontrib>STALA, JOY</creatorcontrib><creatorcontrib>WILLIS-SEVAUX, TRACY, ELLEN</creatorcontrib><creatorcontrib>JUNGE, HARALD</creatorcontrib><creatorcontrib>SHI, ZHENG-ZHENG</creatorcontrib><creatorcontrib>VOGEL, PETER</creatorcontrib><creatorcontrib>MONTGOMERY, CHUCK</creatorcontrib><creatorcontrib>MCLAIN, DINA, REBECCA</creatorcontrib><creatorcontrib>PHILLIPS, HEIDI</creatorcontrib><creatorcontrib>SPARKS, MARY, JEAN</creatorcontrib><creatorcontrib>DING, ZHIYONG</creatorcontrib><creatorcontrib>JUNUTULA, JAGATH, REDDY</creatorcontrib><creatorcontrib>EDWARDS, JOEL</creatorcontrib><creatorcontrib>DESAUVAGE, FREDERIC</creatorcontrib><creatorcontrib>GIRGIS, ROSEMARY</creatorcontrib><creatorcontrib>BYERS-HORNER, ALLISON, ANNE</creatorcontrib><creatorcontrib>CULBERTSON, LING, LING</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PAYNE, BOBBY, JOE</au><au>RANGEL, CAROLINA</au><au>QIAN, NI, NANCY</au><au>MASSEY, ERIN, MARIE</au><au>YE, WEILAN</au><au>COMBS, KATHERIN</au><au>STALA, JOY</au><au>WILLIS-SEVAUX, TRACY, ELLEN</au><au>JUNGE, HARALD</au><au>SHI, ZHENG-ZHENG</au><au>VOGEL, PETER</au><au>MONTGOMERY, CHUCK</au><au>MCLAIN, DINA, REBECCA</au><au>PHILLIPS, HEIDI</au><au>SPARKS, MARY, JEAN</au><au>DING, ZHIYONG</au><au>JUNUTULA, JAGATH, REDDY</au><au>EDWARDS, JOEL</au><au>DESAUVAGE, FREDERIC</au><au>GIRGIS, ROSEMARY</au><au>BYERS-HORNER, ALLISON, ANNE</au><au>CULBERTSON, LING, LING</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO</title><date>2006-12-14</date><risdate>2006</risdate><abstract>The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO69122, PRO204, PRO214, PRO222, PRO234, PRO265, PRO309, PRO332, PRO342, PRO356, PRO540, PRO618, PRO944, PRO994, PRO1079, PRO1110, PRO1122, PRO1138, PRO1190, PRO1272, PRO1286, PRO1295, PRO1309, PRO1316, PRO1383, PRO1384, PRO1431, PRO1434, PRO1475, PRO1481, PRO1568, PRO1573, PRO1599, PRO1604, PRO1605, PRO1693, PRO1753, PRO1755, PRO1777, PRO1788, PRO1864, PRO1925, PRO1926, PRO3566, PRO4330, PRO4423, PRO36935, PRO4977, PRO4979, PRO4980, PRO4981, PRO5801, PRO5995, PRO6001, PRO6095, PRO6182, PRO7170, PRO7171, PRO7436, PRO9912, PRO9917, PRO37337, PRO37496, PRO19646, PRO21718, PRO19820, PRO21201, PRO20026, PRO20110, PRO23203 or PRO35250 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities. La présente invention concerne des animaux transgéniques ainsi que des compositions et des procédés se rapportant à la caractérisation de la fonction génique. De manière plus spécifique, cette invention porte sur des souris transgéniques comprenant des disruptions dans les gènes PRO69122, PRO204, PRO214, PRO222, PRO234, PRO265, PRO309, PRO332, PRO342, PRO356, PRO540, PRO618, PRO944, PRO994, PRO1079, PRO1110, PRO1122, PRO1138, PRO1190, PRO1272, PRO1286, PRO1295, PRO1309, PRO1316, PRO1383, PRO1384, PRO1431, PRO1434, PRO1475, PRO1481, PRO1568, PRO1573, PRO1599, PRO1604, PRO1605, PRO1693, PRO1753, PRO1755, PRO1777, PRO1788, PRO1864, PRO1925, PRO1926, PRO3566, PRO4330, PRO4423, PRO36935, PRO4977, PRO4979, PRO4980, PRO4981, PRO5801, PRO5995, PRO6001, PRO6095, PRO6182, PRO7170, PRO7171, PRO7436, PRO9912, PRO9917, PRO37337, PRO37496, PRO19646, PRO21718, PRO19820, PRO21201, PRO20026, PRO20110, PRO23203 ou PRO35250. De telles études et caractérisations in vivo peuvent assurer une identification intéressante et la découverte de thérapies et/ou de traitements utiles dans la prévention, l'amélioration ou la correction de maladies et de dysfonctionnements associés aux disruptions géniques telles que les troubles neurologiques; les troubles cardio-vasculaires, endothéliaux ou angiogéniques; les anomalies de l'oeil; les troubles immunologiques; les troubles oncologiques; les anomalies ou les troubles du métabolisme osseux; les troubles du métabolisme des lipides; ou les troubles de la croissance.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2006132788A2
source esp@cenet
title NOVEL GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T08%3A35%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PAYNE,%20BOBBY,%20JOE&rft.date=2006-12-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2006132788A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true